Dysgeusia

Dysgeusia is the distortion or decrease of the sense of taste. Dysgeusia is associated with zinc deficiency and some drugs for hypertension or anti-anxiety. It is also found in patients with severe renal insufficiency. (From the Wikpedia article Dysgeusia.)

Download PDF containing detailed information.

Recent Publications on Dysgeusia:
Steroid dysregulation and stomatodynia (burning mouth syndrome). Stomatodynia ( burning mouth syndrome) is characterized by a spontaneous,...	29th October, 2009	Department of Endodontic and Restorative Dentistry, Universite d'Auvergne,	J Orofac Pain. 2009 Summer;23(3):202-10.
Carcinoid tumor of the thymus associated with Cushing's syndrome and dysgeusia: case report and review of the literature. A 30-year-old man was hospitalized with edema, polyuria, and abnormalities...	28th October, 2009	Department of Endocrinology, Hospital Universitari del Mar, Passeig	Endocrine. 2009 Oct 27. DOI Direct Link
A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. BACKGROUND: Dihydroergotamine mesylate (DHE) is an effective treatment for...	17th October, 2009	Swedish Pain and Headache Center, Seattle, WA, USA.	Headache. 2009 Jun;49(6):826-37. DOI Direct Link
Ceftobiprole: a new broad spectrum cephalosporin. Ceftobiprole, formerly designated BAL9141/Ro 63-9141, is a...	9th October, 2009	State University of New York at Buffalo, School of Medicine and Biomedical	Expert Opin Pharmacother. 2009 Jul;10(10):1675-86. DOI Direct Link
Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study. OBJECTIVE: This study was conducted to evaluate salivary...	26th September, 2009	Division of Stomatology and Prevention of Buccomaxillofacial Cancer,	Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Oct;108(4):537-43. DOI Direct Link
→View more research publications.

Press Releases About Dysgeusia:
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients	2nd September, 2008	Alexza Pharmaceuticals, Inc.	MOUNTAIN VIEW, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced positive results from its first Phase 3 clinical trial of AZ-004 (Staccato(R)

BioNews Results for Dysgeusia:
Zolmitriptan nasal spray effective as acute treatment for cluster headache	Reuters Health:  Oct 22 2009 12:59AM Matching: dysgeusia

Dysgeusia Clinical Trials:
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Dysgeusia Patents:
US Patent No.	Title
6936691	Secreted protein HCE3C63
7169805	Captopril derivatives
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Dysgeusia scientists - we have details of around 32 individuals working on Dysgeusia .